TRCT
MBOT icon

Tower Research Capital (TRC)’s Microbot Medical MBOT Stock Holding History

Tower Research Capital (TRC)’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.3K Buy
11,448
+2,901
+34% +$5.91K ﹤0.01% 3455
2026
Q1 		$20.6K Buy
8,547
+7,486
+706% +$16.7K ﹤0.01% 3461
2025
Q4 		$2.12K Sell
1,061
-35,055
-97% -$83K ﹤0.01% 4582
2025
Q3 		$110K Buy
36,116
+34,519
+2,161% +$108K ﹤0.01% 1915
2025
Q2 		$4.02K Sell
1,597
-14,576
-90% -$34.9K ﹤0.01% 4392
2025
Q1 		$24.4K Buy
16,173
+11,767
+267% +$20.8K ﹤0.01% 2783
2024
Q4 		$4.93K Sell
4,406
-569
-11% -$557 ﹤0.01% 4377
2024
Q3 		$4.45K Sell
4,975
-1,801
-27% -$1.75K ﹤0.01% 4538
2024
Q2 		$6.91K Sell
6,776
-1,501
-18% -$1.54K ﹤0.01% 4523
2024
Q1 		$10.2K Buy
8,277
+160
+2% +$203 ﹤0.01% 3735
2023
Q4 		$13.3K Buy
+8,117
New +$10.8K ﹤0.01% 3965
2023
Q2 		– Sell
-5,289
Closed -$11K – 6243
2023
Q1 		$11K Buy
5,289
+1,567
+42% +$4.64K ﹤0.01% 4235
2022
Q4 		$11K Buy
3,722
+1,806
+94% +$7.49K ﹤0.01% 3839
2022
Q3 		$9K Sell
1,916
-365
-16% -$1.88K ﹤0.01% 4667
2022
Q2 		$11K Buy
2,281
+1,169
+105% +$6.5K ﹤0.01% 4379
2022
Q1 		$7K Buy
+1,112
New +$6.52K ﹤0.01% 4736
2020
Q4 		– Sell
-246
Closed -$2K – 5299
2020
Q3 		$2K Buy
+246
New +$1.73K ﹤0.01% 4602
2017
Q1 		– Sell
-2
Closed – – 3559
2016
Q4 		$0 Buy
+2
New +$253 ﹤0.01% 4171
2016
Q1 		– Sell
-3
Closed -$2K – 4600
2015
Q4 		$2K Buy
+3
New +$2.2K ﹤0.01% 3756
2015
Q1 		– Sell
-2
Closed -$4K – 4715
2014
Q4 		$4K Sell
2
-9
-82% -$16.3K ﹤0.01% 2882
2014
Q3 		$23K Buy
11
+10
+1,000% +$26.4K ﹤0.01% 2184
2014
Q2 		$4K Sell
1
-2
-67% -$4.61K ﹤0.01% 3004
2014
Q1 		$7K Sell
3
-6
-67% -$14.3K ﹤0.01% 2971
2013
Q4 		$17K Buy
9
+8
+800% +$16.9K ﹤0.01% 2502
2013
Q3 		$2K Hold
1
– – ﹤0.01% 4120
2013
Q2 		$4K Buy
+1
New +$2.82K ﹤0.01% 3089

Other funds holding MBOT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Tower Research Capital (TRC)'s MBOT Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Microbot Medical (MBOT) stake by 34% in Q2 2026, buying an estimated $5.91K and bringing the position to 11,448 shares worth $22.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3455.

Tower Research Capital (TRC) first reported a position in MBOT in Q2 2013 and has held it in 26 quarters since. The position peaked at $110K in Q3 2025. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Tower Research Capital (TRC) held 11,448 shares of Microbot Medical worth $22.3K as of Q2 2026.
  • Tower Research Capital (TRC) bought 2,901 Microbot Medical shares in Q2 2026, an estimated $5.91K.
  • Microbot Medical made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3455 holding.
  • Tower Research Capital (TRC) first reported a position in Microbot Medical in Q2 2013 and has held it in 26 quarters since.
  • Tower Research Capital (TRC)'s Microbot Medical position peaked at $110K in Q3 2025.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.